| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $913.9M | -9.9% |
| R&D Expense | $62.7M | +2.3% |
| SG&A Expense | $524.0M | -5.5% |
| Operating Income | -$95.2M | +5.2% |
| Interest Expense | $18.3M | +5993.0% |
| Pre-tax Income | -$109.9M | -8.5% |
| Income Tax | -$46.0M | -667.3% |
| Net Income | -$63.9M | +33.0% |
| EPS (Basic) | -$2.45 | +33.1% |
| EPS (Diluted) | -$2.45 | +33.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.6M | -10.8% |
| Accounts Receivable | $169.0M | +2.9% |
| Inventory | $233.9M | -5.2% |
| Current Assets | $537.9M | +0.2% |
| Total Assets | $1.64B | -10.1% |
| Current Liabilities | $217.3M | +17.7% |
| Long-term Debt | $532.2M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.6M | -61.7% |
| Investing Cash Flow | -$28.7M | +52.5% |
| Financing Cash Flow | -$1.3M | -101.8% |
| Total Liabilities |
| $883.5M |
| +135.4% |
| Stockholders' Equity | $758.6M | -47.7% |